Valuation: Ventripoint Diagnostics Ltd.

Market Cap 12.72M 8.88M 8.09M 7.45M 6.78M 822M 13.37M 90.72M 36.06M 449M 33.33M 32.62M 1.41B P/E 2024
-3.22x
P/E 2025 -7.24x
Enterprise Value 15.28M 10.67M 9.72M 8.95M 8.14M 988M 16.06M 109M 43.3M 540M 40.02M 39.18M 1.69B EV / Sales 2024
187x
EV / Sales 2025 145x
Free-Float
98.41%
Yield 2024 *
-
Yield 2025 -

Last Transcript: Ventripoint Diagnostics Ltd.

1 day-7.14%
Current month-18.75%
1 month-27.78%
3 months-35.00%
6 months-55.17%
Current year-53.57%
1 week 0.06
Extreme 0.065
0.07
1 month 0.06
Extreme 0.065
0.1
Current year 0.06
Extreme 0.065
0.19
1 year 0.06
Extreme 0.065
0.19
3 years 0.06
Extreme 0.065
0.36
5 years 0.06
Extreme 0.065
0.41
10 years 0.06
Extreme 0.065
0.92
Manager TitleAgeSince
Chief Executive Officer - 05/02/2024
Chief Executive Officer 74 01/10/2010
Director of Finance/CFO - 03/12/2025
Director TitleAgeSince
Director/Board Member - 29/07/2026
Director/Board Member - 20/12/2021
Chairman 74 17/12/2019
Date Insider Type Main position Quantity % Market Cap. Importance
8/1/26 A Other

Director

0 0.0000%
8/1/26 A Other

Director

0 0.0000%
8/1/26 A Other

Director

0 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-7.14%0.00%-27.78%-53.57% 8.88M
-2.79%-4.38%+13.97%+38.80% 248B
-3.16%-5.43%-3.09%+1.15% 155B
-2.01%-10.04%-28.95%+27.97% 138B
-2.35%-5.32%-56.67%-24.11% 60.85B
-1.95%-4.95%+19.64%+52.11% 58.56B
-1.96%-2.25%+2.85%-14.73% 52.46B
-2.83%-2.06%+12.65%+37.49% 48.04B
-3.51%-4.30%+11.79%+60.37% 43.29B
+1.26%-11.71%+9.08%+50.92% 43.1B
Average -2.64%-3.79%-4.65%+17.64% 85B
Weighted average by Cap. -2.42%-3.87%-1.96%+24.88%

Financials

2024 2025
Net sales 95.17K 66.45K 60.52K 55.77K 50.73K 6.15M 100K 679K 270K 3.36M 249K 244K 10.55M 180K 126K 114K 105K 95.91K 11.63M 189K 1.28M 510K 6.35M 471K 461K 19.94M
Net income -4.92M -3.44M -3.13M -2.88M -2.62M -318M -5.17M -35.09M -13.95M -174M -12.89M -12.62M -545M -3.2M -2.23M -2.04M -1.88M -1.71M -207M -3.36M -22.82M -9.07M -113M -8.38M -8.21M -355M
Net Debt 1.57M 1.1M 1M 923K 839K 102M 1.65M 11.23M 4.46M 55.6M 4.12M 4.04M 174M 2.56M 1.78M 1.63M 1.5M 1.36M 165M 2.69M 18.23M 7.25M 90.27M 6.7M 6.56M 283M
Projected Income Statement - Annual - Ventripoint Diagnostics Ltd.
Logo Ventripoint Diagnostics Ltd.
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.
Employees
-
Date Price Change Volume
20/11/26 CA$0.0650 -7.14% 4,200
19/11/26 CA$0.0700 0.00% 20,353
18/11/26 CA$0.0700 +7.69% 7,779
17/11/26 CA$0.0650 0.00% 25,000
16/11/26 CA$0.0650 0.00% 24,052